glp-1 and blood pressure Possible mechanisms of action of glucagon-like peptide-1 receptor agonists on beyond body weight GLP-1 and High Blood Pressure:

Experiencing acid reflux on GLP-1 medications

Heart palpitations during semaglutide treatment are a real concern for some patients

This global initiative reframed obesity as a chronic, systemic disease rather than a mere risk factor

June 2, 2026 Results of an American College of Radiology-managed retrospective study involving 110,000 womenpresented at the 2026 ASCO Annual Meeting, shows that those who took GLP-1 medications were up to 35% less likely to develop breast cancer than those who did not take GLP-1 drugs. ACR urges funding of a large prospective study to clarify impact of these drugs on cancer incidence and prevention.

Weight management concerns should be eva